BioCentury
ARTICLE | Company News

Applied Molecular in optimization deal with Biosynexus

December 20, 2000 8:00 AM UTC

AMEV will use its directed evolution technology to optimize for Biosynexus (Rockville, Md.) a prophylactic antibody for staphylococcus bacterial infections in neonatal and pediatric patients. AMEV wil...